Splenic irradiation combined with plasmapheresis and rituximab: a new option reducing donor-specific antibody in haploidentical hematopoietic stem cell transplantation

Bone Marrow Transplant. 2023 Feb;58(2):226-228. doi: 10.1038/s41409-022-01868-3. Epub 2022 Nov 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Plasmapheresis
  • Rituximab / therapeutic use
  • Tissue Donors
  • Transplantation Conditioning

Substances

  • Rituximab
  • Antibodies